Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats

被引:29
作者
Church, Rachel J. [1 ]
Otieno, Monicah [2 ]
McDuffie, James Eric [3 ]
Singh, Bhanu [2 ]
Sonee, Manisha [2 ]
Hall, LeRoy [2 ]
Watkins, Paul B. [1 ]
Ellinger-Ziegelbauer, Heidrun [4 ]
Harrill, Alison H. [1 ,5 ]
机构
[1] Hamner UNC Inst Drug Safety Sci, Res Triangle Pk, NC 27709 USA
[2] Janssen Res & Dev LLC, Preclin Dev & Safety, Spring House, PA 19477 USA
[3] Janssen Res & Dev LLC, Preclin Dev & Safety, San Diego, CA 92121 USA
[4] Bayer Pharma AG, Invest Toxicol, GDD GED Tox, D-42096 Wuppertal, Germany
[5] Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, 4301 W Markham St, Little Rock, AR 72205 USA
基金
美国国家卫生研究院;
关键词
drug-induced liver injury; biomarkers; miRNA; hepatobiliary injury; biliary hyperplasia; INDUCED LIVER-INJURY; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; TUBULAR INJURY; EXPRESSION; URINARY; HEPATITIS; PROFILES; FIBROSIS; REVEALS;
D O I
10.1093/toxsci/kfv260
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Identification of circulating microRNAs for the diagnosis of liver injury and as an indicator of underlying pathology has been the subject of recent investigations. While several studies have been conducted, with particular emphasis on miR-122, the timing of miRNA release into the circulation and anchoring to tissue pathology has not been systematically evaluated. In this study, miRNA profiling was conducted over a time course of hepatobiliary injury and repair using alpha-naphthylisothiocyanate (ANIT) and a proprietary compound, FP004BA. ANIT administration (50 mg/kg) to rats caused significant biliary epithelial cell and hepatocellular necrosis between 24 and 72 h, followed by resolution and progression to biliary hyperplasia by 120 h which was associated with miRNA release into the blood. FP004BA (100 mg/kg) was used to confirm associations of miRNA along a time course with similar hepatic pathology to ANIT. Treatment with ANIT or FP004BA resulted in significant alterations of overlapping miRNAs during the early and peak injury phases. In addition to well-characterized liver injury markers miR-122aEuroE5p and miR-192aEuroE5p, multiple members of the 200 family and the 101 family along with miR-802aEuroE5p and miR-30daEuroE5p were consistently elevated during hepatobiliary injury caused by both toxicants, suggesting that these species may be potential biomarker candidates for hepatobiliary injury. After 14 days of dosing with 4BA, miR-182aEuroE5p remained elevated-while miR-122aEuroE5p and miR-192aEuroE5p had returned to baseline-suggesting that miR-182aEuroE5p may have added utility to monitor for hepatobiliary injury in the repair phases when there remains histological evidence of ongoing cellular injury.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 31 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   MicroRNA-34c-3p is an early predictive biomarker for doxorubicin-induced glomerular injury progression in male Sprague-Dawley rats [J].
Church, Rachel J. ;
McDuffie, J. Eric ;
Sonee, Manisha ;
Otieno, Monicah ;
Ma, Jing Ying ;
Liu, Xuejun ;
Watkins, Paul B. ;
Harrill, Alison H. .
TOXICOLOGY RESEARCH, 2014, 3 (05) :384-394
[3]   Time Course Gene Expression Using Laser Capture Microscopy-Extracted Bile Ducts, but Not Hepatic Parenchyma, Reveals Acute Alpha-Naphthylisothiocyanate Toxicity [J].
Cullen, John Michael ;
Falls, James Greg ;
Brown, Harlan Roger ;
Yoon, Lawrence Wonsik ;
Cariello, Neal Foster ;
Faiola, Brenda ;
Kimbrough, Carie Lynette ;
Jordan, Holly Lynn ;
Miller, Richard Thomas .
TOXICOLOGIC PATHOLOGY, 2010, 38 (05) :715-729
[4]   Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis [J].
Dear, James W. ;
Antoine, Daniel J. ;
Starkey-Lewis, Philip ;
Goldring, Christopher E. ;
Park, B. Kevin .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (05) :904-905
[5]   The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury [J].
Ellinger-Ziegelbauer, Heidrun ;
Adler, Melanie ;
Amberg, Alexander ;
Brandenburg, Arnd ;
Callanan, John J. ;
Connor, Susan ;
Fountoulakis, Michael ;
Gmuender, Hans ;
Gruhler, Albrecht ;
Hewitt, Philip ;
Hodson, Mark ;
Matheis, Katja A. ;
McCarthy, Diane ;
Raschke, Marian ;
Riefke, Bjoern ;
Schmitt, Christina S. ;
Sieber, Max ;
Sposny, Alexandra ;
Suter, Laura ;
Sweatman, Brian ;
Mally, Angela .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 252 (02) :97-111
[6]   Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy [J].
Fang, Lu ;
Ellims, Andris H. ;
Moore, Xiao-lei ;
White, David A. ;
Taylor, Andrew J. ;
Chin-Dusting, Jaye ;
Dart, Anthony M. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
[7]  
Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11
[8]   The microRNA-30 Family Is Required for Vertebrate Hepatobiliary Development [J].
Hand, Nicholas J. ;
Master, Zankhana R. ;
Eauclaire, Steven F. ;
Weinblatt, Daniel E. ;
Matthews, Randolph P. ;
Friedman, Joshua R. .
GASTROENTEROLOGY, 2009, 136 (03) :1081-1090
[9]   The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers [J].
Harrill, A. H. ;
Roach, J. ;
Fier, I. ;
Eaddy, J. S. ;
Kurtz, C. L. ;
Antoine, D. J. ;
Spencer, D. M. ;
Kishimoto, T. K. ;
Pisetsky, D. S. ;
Park, B. K. ;
Watkins, P. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) :214-220
[10]   Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats [J].
Kanki, Masayuki ;
Moriguchi, Akira ;
Sasaki, Daisuke ;
Mitori, Hikaru ;
Yamada, Atsushi ;
Unami, Akira ;
Miyamae, Yoichi .
TOXICOLOGY, 2014, 324 :158-168